Search For "covaxin"
COVAXIN trial results on children likely by September: AIIMS chief
Updated : 1 day, 4 hours ago IST
New Delhi [India], July 24 (ANI): Trials for Bharat Biotech's Covid-19 vaccine Covaxin on children are underway and results are expected to be released by September, All India Institute of Medical Sciences (AIIMS) director Randeep Guleria informed.
Read More
Bharat Biotech cancels contracts with 2 Brazil firms for Covaxin
Updated : 1 day, 19 hours ago IST
New Delhi [India], July 23 (ANI): Bharat Biotech on Friday said it has terminated agreements it had signed with two Brazilian companies - Precisa Medicamentos and Envixia Pharmaceuticals LLC to introduce its Covid-19 Covaxin in Brazil.
Read More
COVID-19: Second dose trial of Covaxin on 2-6 years to begin by ne
Updated : 2 days, 19 hours ago IST
New Delhi [India], July 23 (ANI): As part of its COVID-19 vaccination trials for children, Bharat Biotech is likely to administer the second dose of Covaxin to children aged between 2 and 6 years next week, sources said on Thursday.
Read More
Bharat Biotech dossier under review for Covaxin emergency use list
Updated : 5 days, 23 hours ago IST
New Delhi [India], July 19 (ANI): Officials of the World Health Organisation (WHO) had a meeting with those of Bharat Biotech and the Hyderabad-based vaccine maker's dossier for Emergency Use Listing (EUL) of Covaxin is under review by the technical experts for consideration, Dr Poonam Kh
Read More
Vega City Mall bucks the trend post second wave, recovery in footf
Updated : 1 week, 1 day ago IST
Bengaluru (Karnataka) [India], July 17 (ANI/BusinessWire India): Vega City Mall, South Bangalore's most happening mall has reported a dramatic recovery in footfalls in Week 15 of this financial year. It was not only footfalls that Vega City witnessed but the number of four wheelers and two w
Read More
Will receive EUL for Covaxin from WHO at earliest, says Bharat Bio
Updated : 1 week, 5 days ago IST
Hyderabad (Telangana) [India], July 12 (ANI): With a review process of 'Covaxin', the indigenous vaccine against COVID-19 commencing at the World Health Organisation (WHO), the Hyderabad-based Bharat Biotech on Monday said it expects to receive emergency use listing (EUL) from the global bod
Read More
EUL to Covaxin from WHO expected in first week of August: Sources
Updated : 2 weeks, 1 day ago IST
Geneva [Switzerland], July 10 (ANI): The World Health Organisation (WHO) is likely to take a decision on Emergency Use Listing (EUL) of Bharat Biotech's Covaxin and announce it in the first week of August.
Read More
With a day of Covaxin stock left, Punjab CM calls for more supplie
Updated : 2 weeks, 1 day ago IST
Chandigarh (Punjab) [India], July 9 (ANI): Punjab Chief Minister Captain Amarinder Singh on Friday reiterated the need for an increase in COVID-19 vaccine supply from the Centre.
Read More
Union Minister Mansukh Mandaviya visits COVID-19 vaccine manufactu
Updated : 2 weeks, 6 days ago IST
Ahmedabad (Gujarat) [India], July 4 (ANI): Union Minister of State for Chemicals and Fertilisers Mansukh Mandaviya on Sunday visited the COVID-19 vaccine manufacturing facilities of Zydus Cadila and Hester Biosciences in Gujarat.
Read More
Brazilian Supreme Court approves investigation of Bolsonaro over C
Updated : 3 weeks ago IST
Buenos Aires [Argentina], July 3 (ANI/Sputnik): The Supreme Federal Court of Brazil has approved a probe into President Jair Bolsonaro regarding alleged overpricing during the purchase of India's coronavirus vaccine Covaxin, the G1 website reported.
Read More
After release of Covaxin's phase 3 efficacy data, NTAGI chief says
Updated : 3 weeks ago IST
New Delhi [India], (ANI): Hours after Bharat Biotech announced that its vaccine Covaxin's efficacy against COVID-19 is 77.8 per cent, National Technical Advisory Group on Immunisation (NTAGI) Chief Dr NK Arora said that these results will help the vaccine get recognition from the World Healt
Read More
Bharat Biotech releases Phase 3 trial results of Covaxin, claims v
Updated : 3 weeks, 1 day ago IST
Hyderabad (Telangana) [India], July 3 (ANI): Hyderabad-based Bharat Biotech on Saturday concluded a final analysis for its vaccine Covaxin efficacy from phase-3 clinical trial claiming it to be 77.8 per cent effective against COVID-19.
Read More